ST. CLOUD, Minn. — MicroBioLogics announced its new relationship with local investment group Granite Equity Partners.
In the next phase of the company’s growth, two partners from Granite Equity will join MicroBioLogics as members of its board of directors. Their unique backgrounds with strong science and business leadership experience make them well suited to assist MicroBioLogics in facilitating growth and development strategies.
“MicroBioLogics is a strong company with a lot of potential for growth. We are happy to have this opportunity and look forward to a long-term partnership with them,” said Granite Equity Partners co-founder and partner Patrick K. Edeburn.
MicroBioLogics CEO Robert Coborn said his company’s recent roll out of its License and Supply Program, as well as its work to achieve ISO 17025:2005 accreditation and expand its distributor network, necessitated the help of a partner like Granite.
“We chose to work with Granite Equity Partners because they share our commitment to making a positive impact in our community and preserving the longstanding relationships we have built with our loyal employees. I am certain this relationship will give MicroBioLogics the means to realize its full potential,” Coborn said.
Granite Equity Partners is a Minnesota-based private equity firm focused on buyouts, recapitalizations and growth equity investment with more than four decades of experience and management expertise.